Conquering Diseases

Study Of An Investigational Drug For Autologous Stem Cell Transplant To Treat Multiple Myeloma

Description

Seeking men and women who have Multiple Myeloma (MM) and will undergo Autologous Stem Cell Transplant (ASCT) as a form of treatment for a study of an investigational drug to help collect blood stem cells.

Overview

Participants in this study will either get the investigational drug combination or the standard drug combination to aid in collecting their blood stem cells for use in Autologous Stem Cell Transplant (ASCT) to treat multiple myeloma.

What we're hoping for

We are studying an investigational drug compared to the standard drug combination to see if it helps improve collection of blood stem cells to be used in Autologous Stem Cell Transplant (ASCT) to treat multiple myeloma

Additional Information

ClinicalTrials.gov Identifier: NCT05561751

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989